paper summary2

Upload: euler96

Post on 31-May-2018

225 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/14/2019 Paper Summary2

    1/27

    Paper Summary

    Monotone Smoothing with Application to

    Dose-Response Curves and

    the Assessment of Synergism

    Colleen Kelly and John Rice, Biometrics,

    Vol. 46, No. 4, (Dec., 1990), pp. 1071-1085

  • 8/14/2019 Paper Summary2

    2/27

    Outline

    Introduction

    Monotone Smoothing

    Assessing SynergismBootstrap Method

    Procedure

    ApplicationResult

  • 8/14/2019 Paper Summary2

    3/27

    Monotone Smoothing

    0 1 1

    1

    To monotone smoothing is based on spline

    function. Given a partition

    ... of an interval [ , ]

    a spline function is a polynomial on each

    interval [ , ).

    We shall refer to the as "kno

    p

    j j

    i

    a b a b

    ts".

  • 8/14/2019 Paper Summary2

    4/27

    Monotone Smoothing

    Given data points ( , ) ( 1,..., ), a smoothing

    spline is the function that minimizes

    i i x y i n

    1

    2 2

    1

    ( ) ( ( )) [ ( )]n

    n x

    i ix

    i

    Q Y x x dx

    The minimizing is a cubic spline with

    a knot at every data point.

  • 8/14/2019 Paper Summary2

    5/27

    Monotone Smoothing

    as 0, tends to an interpolant of the data.

    The smaller is, the quicker the running time,

    especially when 0.

    p

    as , tends to the LS line fit to the data.

  • 8/14/2019 Paper Summary2

    6/27

  • 8/14/2019 Paper Summary2

    7/27

  • 8/14/2019 Paper Summary2

    8/27

    Monotone Smoothing

    Knot placement should depend on the density

    of data points or on local behavior of curve.

    Thus we control smoothing only with .

    1. Chosen the amount of smoothing to apply .

    2. Leave-one-out cross-validation.

    3. Doing a preliminary QR decomposition.

  • 8/14/2019 Paper Summary2

    9/27

    Assessing Synergism

    Synergistic if its effect is more than

    would be expected form what is known

    about the effect of the individuak

    constituent.

    Antagonistic if the effect is less.

    Asynergistic if effect is the same.

  • 8/14/2019 Paper Summary2

    10/27

    Assessing Synergism

    Definition of synergism:

    Let the repsone to dosages and of two

    drug be denote by ( , ).

    Assume 0 0, and ( ,0) (0, ) are

    monotone.

    x y

    f x y

    x y f x f y

  • 8/14/2019 Paper Summary2

    11/27

    Assessing Synergism

    For given response value let and be

    those dosages such that ( ,0) (0, ) .

    if ( , ) , 1.

    Synergistic if left side is less than 1.

    Antagonistic if it is greater than 1.

    z z

    z z

    z z

    z x y

    f x f y z

    x y f x y z x y

  • 8/14/2019 Paper Summary2

    12/27

    Bootstrap Method

    Parametric bootstrap samples

    Model could be binomial or poisson.

    2

    *( )

    i

    *(b) *( )

    , ~(0, ), independent.bootstrap residuals

    : 1... : 1...

    bootstrap sample for Y is Y .

    b

    b

    Y X

    i n b B

    X

  • 8/14/2019 Paper Summary2

    13/27

    Procedure

    Monotone spline

    Parametric bootstrap sample

    Check synergism

  • 8/14/2019 Paper Summary2

    14/27

    Application I

    Data form Le Pelley and Sullivan

    (1936).

    Alcoholic solutions of rotenone,

    pyrethrins, and a mixture of the two.

    The mixture series was 1:5 ratio and

    1:15 ratio.

  • 8/14/2019 Paper Summary2

    15/27

  • 8/14/2019 Paper Summary2

    16/27

  • 8/14/2019 Paper Summary2

    17/27

  • 8/14/2019 Paper Summary2

    18/27

  • 8/14/2019 Paper Summary2

    19/27

    Application I

    2

    2

    Calculations

    for the 1:5 ratio, (3) 81.19 was synergism.

    for the 1:15 ratio, (3) 11.72 which is

    not significant at 0.05.

  • 8/14/2019 Paper Summary2

    20/27

    Application I

    Bliss (1939);

    Finney, using probit analysis (1952);

    Chou and Talalay with median effect

    analysis (1983)

    All investigators concluded there was

    synergism in the 1:5 ratio and slight

    synergism in the 1:15 ratio.

  • 8/14/2019 Paper Summary2

    21/27

    Application II

    Data form Dr Stephen Howell of the UCSD

    Cancer Center.

    Ovarian cancer may be treated by VP-16 and

    DPM.

    There are 6 concentration levels for each

    individual dose-reponse curve, with 18

    observations.There are 4 combination doses ratio 1:150 of

    VP-16/DPM.

  • 8/14/2019 Paper Summary2

    22/27

  • 8/14/2019 Paper Summary2

    23/27

  • 8/14/2019 Paper Summary2

    24/27

  • 8/14/2019 Paper Summary2

    25/27

    Application II

    Parametric bootstrap based on Poisson

    model for the random variability under

    asynergy.

    Responses are to increasing

    concentrations of a conmbination of both

    drugs in a 1:150 ratio.

  • 8/14/2019 Paper Summary2

    26/27

    Reference

    Howell, S. B., Sanga, R., Vick, J., and Abramson, I. (1989a).

    Comparison of the Synergistic Potentiation of Etoposide,

    Doxorubicin, and Vinblastine Cytotoxicity by Dipyridamole.

    Cancer Research 49, 4147-4153.

    , , lecture5, lecture6, lecture7.

  • 8/14/2019 Paper Summary2

    27/27

    Thank you for your listening.